Compare market size and growth of key Healthcare markets

Compare market size and growth of key Healthcare markets

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Loading...

Categories

10 Indonesia Hyperglycemics Reports

Asia Pacific SGLT2 Inhibitors Market

Country Covered: Indonesia

Study Period: 2019 - 2030

Major Players: Eli Lilly and Company, Boehringer Ingelheim, Janssen, AstraZeneca, Bristol-Myers Squibb

APAC Biguanide Industry

Country Covered: Indonesia

Study Period: 2019 - 2030

Major Players: Takeda Pharmaceuticals, Bristol-Myers Squibb, Glenmark Pharmaceuticals, Merck, Sanofi

APAC Insulin Market

Country Covered: Indonesia

Study Period: 2019 - 2030

Major Players: Novo Nordisk, Eli Lilly and Company, Sanofi, Biocon, Gan & Lee

APAC Meglitinide Industry

Country Covered: Indonesia

Study Period: 2019 - 2030

Major Players: Novo Nordisk, Glenmark Pharmaceuticals, Novartis, KISSEI PHARMACEUTICAL, Biocon

Meglitinides Market

Country Covered: Indonesia

Study Period: 2019 - 2030

Major Players: Glenmark Pharmaceuticals, Novartis, KISSEI PHARMACEUTICAL, Biocon, Novo Nordisk

SGLT2 Inhibitors Market

Country Covered: Indonesia

Study Period: 2019 - 2030

Major Players: Janssen, Eli Lilly and Company, Bristol-Myers Squibb, AstraZeneca, Astellas Pharma

Glargine Insulin Market

Country Covered: Indonesia

Study Period: 2019 - 2030

Major Players: Sanofi, Novo Nordisk, Biocon, Eli Lilly and Company, Julphar

Basal Insulin (Long-Acting Insulin) Market

Country Covered: Indonesia

Study Period: 2019 - 2030

Major Players: Novo Nordisk, Sanofi, Eli Lilly and Company, Biocon, Wockhardt

Sulfonylureas Industry

Country Covered: Indonesia

Study Period: 2019 - 2030

Major Players: Sanofi, Pfizer, Merck, Torrent Pharmaceuticals, Dr. Reddy’s Laboratories

Biguanides Market

Country Covered: Indonesia

Study Period: 2019 - 2030

Major Players: Bristol-Myers Squibb, Glenmark Pharmaceuticals, Takeda Pharmaceuticals, Sanofi, Merck